Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SSUPERNUS PHARMACEUTICALS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

SUPERNUS PHARMACEUTICALS, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Aug 12, 2026DEC TIMOTHY CSenior Vice-President & CFO604Common Stock$28.8KTax withholding
Aug 12, 2026DEC TIMOTHY CSenior Vice-President & CFO1,250Common Stock$59.6KExercise / conversion
Aug 12, 2026Bhatt Padmanabh P.Sr. VP of IP, CSO1,158Common Stock$55.2KTax withholding
Aug 12, 2026Bhatt Padmanabh P.Sr. VP of IP, CSO2,500Common Stock$119.1KExercise / conversion
Aug 12, 2026Khattar Jack A.President, CEO12,642Common Stock$602.3KTax withholding
Aug 12, 2026Khattar Jack A.President, CEO29,849Common Stock$1.4MExercise / conversion
Aug 12, 2026Mottola FrankSVP, Chief Tech. Ops. Officer797Common Stock$38KTax withholding
Aug 12, 2026Mottola FrankSVP, Chief Tech. Ops. Officer1,650Common Stock$78.6KExercise / conversion
Aug 12, 2026Rubin JonathanSVP, Chief Medical Officer363Common Stock$17.3KTax withholding
Aug 12, 2026Rubin JonathanSVP, Chief Medical Officer750Common Stock$35.7KExercise / conversion
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
$43.75Close · Sep 22, 2026